Please login to the form below

Not currently logged in
Email:
Password:

acute myeloid leukemia

This page shows the latest acute myeloid leukemia news and features for those working in and with pharma, biotech and healthcare.

FDA places partial clinical hold on three Gilead phase 3 trials for MDS and AML treatments

FDA places partial clinical hold on three Gilead phase 3 trials for MDS and AML treatments

for patients with myelodysplastic syndrome (MDS), acute myeloid leukaemia (AML) and AML patients unable to receive intensive chemotherapy. ... Speaking on the company’s commitment to developing new MDS therapies, Parsey said: “Considering the high

Latest news

More from news
Approximately 2 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...